ReviewMolecular oncology2021
Tobacco control policies in the 21st century: achievements and open challenges.
Review in Molecular oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
61 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of secondhand smoke on air quality in partially enclosed outdoor hospitality venues: a review.BMC public health · 2024Pooled it
- Harnessing Hope and Bolstering Knowledge of How to Quit: A Qualitative Investigation of Including Efficacy Content in Tobacco Risk Communication via Daily SMS.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025Trial
- Tobacco Smoking and Cardiovascular Health in Africa: Trends, Interventions, and Policy Implications-A Narrative Review.Health science reports · 2026Article
- Article
- Point-of-sale, court-ordered, cigarette-related corrective statements: population prevalence of exposure and reactions.Tobacco control · 2026Article
- Global, regional, and national burden of chronic respiratory diseases among perimenopausal women, 1990-2021: an analysis for the Global Burden of Disease Study 2021.Journal of thoracic disease · 2026Article
- Trends and Disparities in Ischemic Heart Disease and Pneumonia Associated Mortality in the United States: A Population-Based Retrospective Analysis of Death Records From 1999 to 2023.Journal of epidemiology and global health · 2026Article
- Country governance of antimicrobial resistance (AMR) surveillance: observations on global progress and aid programme effectiveness using data from the Tracking AMR Country Self-Assessment Survey (TrACSS).Globalization and health · 2026Article
- The long-term impact of Spain's 2010 Anti-Smoking Law: A counterfactual and prospective time-series analysis.AIMS public health · 2026Article
- Regional, demographic, and temporal trends in psychoactive substance use-related mental disorder and cancer mortality in U.S. adults: a nationwide CDC WONDER analysis (1999-2020).Frontiers in oncology · 2026Article
- European Code Against Cancer, 5th edition - tobacco and nicotine containing products, second-hand smoke, alcohol and cancer.Molecular oncology · 2026Review
- Eradication of commercial tobacco related disease and death.Tobacco control · 2025Article
- Knowledge, attitudes, and practices of community pharmacists on pharmacological approaches to smoking cessation in Saudi Arabia.BMC health services research · 2025Article
- Trends in smoking tobacco in Africa, 1990-2019: analysis from the global burden of disease study 2019.BMC public health · 2025Article
- Unveiling the socio contextual triggers of smokeless tobacco use among blue collar workers: implications for workplace health and policy.Scientific reports · 2025Article
- Social determinants of support for tobacco control policies to end the use of commercial cigarettes: findings from the 2022 International Tobacco Control Four Country Smoking and Vaping Survey.Tobacco control · 2025Article
- Burden of chronic respiratory diseases and their attributable risk factors in 204 countries and territories, 1990-2021: Results from the global burden of disease study 2021.Chinese medical journal pulmonary and critical care medicine · 2025Article
- Article
- Trends in the prevalence and factors associated with indoor smoking in 24 countries Party to the WHO FCTC: implications for equitable policy implementation.BMJ global health · 2025Article
- Impact of tobacco control policies on socioeconomic inequalities in smoking prevalence and quit ratios: an ecological study in the European Union (2009-2020).BMJ public health · 2025Article
1 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Noncommunicable diseases (NCDs), including cancer, are responsible for almost 70% of all deaths worldwide. Tobacco use is a risk factor common to most NCDs. This article discusses tobacco control policies and highlights major achievements and open challenges to reduce smoking prevalence and attributable morbidity and mortality in the 21st century. The introduction of the WHO Framework Convention on Tobacco Control in 2005 has been a key achievement in the field and has already facilitated a drop in both smoking prevalence and exposure to secondhand smoke. Indicatively, the size of the worldwide population benefiting from at least one cost-effective tobacco control policy has quadrupled since 2007. In addition, plain cigarette packaging has been successfully introduced as a tobacco control policy, surmounting efforts of the tobacco industry to challenge this based on trade and investment law. Nevertheless, tobacco control still faces major challenges. Smoking prevalence needs to be further reduced in a rather expedited manner. Smoke-free environments should be extended, and the use of plain tobacco packaging with large pictorial health warnings for all tobacco products should be further promoted in some parts of the world. Some of these measures will require prompt determination and diligence. For example, bold political decisions are needed to significantly increase real prices of tobacco products through excise taxes, ban added ingredients that are currently used to increase the attractiveness of tobacco products and ban the tobacco industry's corporate social responsibility initiatives. Finally, the debate on harm reduction strategies for tobacco control still needs to be resolved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.